| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 03/11/2004 | US20040048858 Chalcone derivatives and their use to treat diseases |
| 03/11/2004 | DE10238865A1 New carboxamides are melanin-concentrating hormone receptor antagonists, useful for treating e.g. metabolic diseases, diabetes, eating disorders, cardiovascular disease, emotional disorders, reproductive and memory disorders |
| 03/11/2004 | CA2496887A1 Oxytocin inhibitors |
| 03/11/2004 | CA2496452A1 Inhibitors of post-amadori advanced glycation end products |
| 03/11/2004 | CA2495914A1 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 03/10/2004 | EP1396487A1 Phenylpyridine carbonyl piperazine derivative |
| 03/10/2004 | EP1395571A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 03/10/2004 | EP1395562A1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- 2,3']bipyridinyl in pure crystalline form and process for synthesis |
| 03/10/2004 | EP1395561A1 Carbamate and oxamide compounds as inhibitors of cytokine production |
| 03/10/2004 | EP1395553A1 Pyrrolidine derivatives as factor xa inhibitors |
| 03/10/2004 | EP1395551A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases |
| 03/10/2004 | EP1395548A1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments |
| 03/10/2004 | EP1395265A2 Combretastatin a-3 prodrug |
| 03/10/2004 | EP1395251A2 Aminediols as agents for the treatment of alzheimer's disease |
| 03/10/2004 | EP1303249B1 Antimycotic nail varnish composition |
| 03/10/2004 | CN1481382A Isoindolin-1-one glucokinase activators |
| 03/10/2004 | CN1481377A Cyclic Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF alhpa |
| 03/10/2004 | CN1481376A Oxybenzamides derivatives as factor xa inhibitors |
| 03/10/2004 | CN1481368A Gyrase imhibitors and uses thereof |
| 03/10/2004 | CN1481364A Urea and urethane derivatives as integrin inhibitors |
| 03/10/2004 | CN1481358A Carboxylic acid amide derivatives and their use in treatment of thromboembolic diseases and tumours |
| 03/10/2004 | CN1481355A Process for prepn. of acylphenylalanines |
| 03/10/2004 | CN1481238A Aniline derivatives or salts thereof and cytokine prodn inhibitors contg. same |
| 03/10/2004 | CN1141096C Use of 1-hydroxy-2-pyridones for treatment of skin diseases |
| 03/09/2004 | US6703525 Antiinflammatory agents; coupling sulfonyl halide with aromatic amine compound |
| 03/09/2004 | US6703509 Reduction of 5-arylnicotinic acids by catalytic hydrogenation in the presence of carboxylic anhydrides in which the catalyst used is a palladium/ligand complex to produce aryinicotinaldehydes |
| 03/09/2004 | US6703425 Sulfonamide derivatives |
| 03/09/2004 | US6703420 Amino-thio-acrylonitriles as MEK inhibitors |
| 03/09/2004 | US6703379 Benzene derivatives and pharmaceutical use thereof |
| 03/09/2004 | US6703368 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 03/09/2004 | CA2260016C Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 03/04/2004 | WO2004018436A2 Compounds derived from aryl carbamates, preparation thereof and uses of same |
| 03/04/2004 | WO2004018428A1 Antibacterial benzoic acid derivatives |
| 03/04/2004 | WO2004018427A1 O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives |
| 03/04/2004 | WO2004018415A1 Sulfonamide derivatives, insecticides for agricultural and horticultural use, and usage thereof |
| 03/04/2004 | WO2004018414A2 Antibacterial agents |
| 03/04/2004 | WO2004017920A2 Novel biphenyl and biphenyl-like cannabinoids |
| 03/04/2004 | WO2003094845A3 Pyridine-based thyroid receptor ligands |
| 03/04/2004 | WO2003075907A3 Small molecule entry inhibitors |
| 03/04/2004 | WO2003045878A3 2,w-diaminocarboxylic acid compounds |
| 03/04/2004 | WO2003043735A3 Aromatic compounds containing nitrogen and p-functionalized amines, the production thereof and their use in catalytic reactions |
| 03/04/2004 | WO2003042166A3 PROCESS FOR PREPARATION OF α-HYDROXYCARBOXYLIC ACID AMIDES |
| 03/04/2004 | WO2002096867A3 Inhibitors of protein kinase for the treatment of disease |
| 03/04/2004 | WO2002072654A3 Polymers and oligomers, their synthesis, and electronic devices incorporating same |
| 03/04/2004 | WO2002070469A3 Selective pde3b inhibitors and use of the same in therapy |
| 03/04/2004 | US20040044251 Optical communication |
| 03/04/2004 | US20040044149 Cr complexes and their use for the polymerization of alpha-olefins |
| 03/04/2004 | US20040044051 Cannabinoid receptor agonists |
| 03/04/2004 | US20040044049 Compounds for inhibiting insulin secretion and methods related thereto |
| 03/04/2004 | US20040044048 Anticholesterol agents; cardiovascular disorders |
| 03/04/2004 | US20040044047 Alpha and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 03/04/2004 | US20040044044 Thiazolyl urea compounds and methods of uses |
| 03/04/2004 | US20040044041 2-(Biarylalkyl)amino-3-(cyanoalkanoylamino)pyridine derivatives |
| 03/04/2004 | US20040044040 Pyridinyl amides and imides for use as fungicides |
| 03/04/2004 | US20040044037 Sleep disorders; antidepressants; analgesics; central nervous system disorders |
| 03/04/2004 | US20040044009 Drug abuse; cental nervous system disorders; cognition activators |
| 03/04/2004 | US20040044008 Dietetics; antilipemic agents; non-insulin dependent diabetes; cardiovascular disorders |
| 03/04/2004 | US20040044004 Calcium channel inhibitors comprising benzhydril spaced from piperazine |
| 03/04/2004 | US20040044003 Therapeutic agents useful for treating pain |
| 03/04/2004 | US20040044002 Kinase inhibitors; antiproliferative agents; antiinflammatory agents; autoimmune diseases; skin disorders; anticancer agents; antiproliferative agents |
| 03/04/2004 | US20040043994 Antitumor agents, endometriosis, vision defects, antiarthritic agents, angiogenesis inhibitors |
| 03/04/2004 | US20040043989 Therapy for drug resistant bacteria; topoisomerase inhibitor |
| 03/04/2004 | US20040043988 Cycloalkyl alkanoic acids as intergrin receptor antagonists |
| 03/04/2004 | US20040043903 2-Aryl-5-trifluoromethylpyridines |
| 03/04/2004 | US20040040840 Controller for redox system |
| 03/04/2004 | DE10239905A1 Substituierte Pyridine oder Pyrimidine, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel Substituted pyridines or pyrimidines, processes for their preparation, compositions containing them and their use as pesticides |
| 03/04/2004 | DE10239481A1 New 1-(heterocyclyl-carbonylamino)-cyclopropane-carboxylic acid derivatives, useful as microbicides, especially fungicides or bactericides for protection of plants or materials such as wood |
| 03/04/2004 | CA2495903A1 Novel biphenyl and biphenyl-like cannabinoids |
| 03/03/2004 | EP1394171A1 Multinuclear metal complexes as Phosphorescence emitter in electroluminescent layered structure |
| 03/03/2004 | EP1394162A1 Intermediates of azole antifungal agents and processes for the preparation thereof |
| 03/03/2004 | EP1394152A1 2-iminoimidazole derivatives (1) |
| 03/03/2004 | EP1394150A1 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists |
| 03/03/2004 | EP1394149A1 Process for the preparation of 1-(6-Methylpyridin-3-yl)-2-[4-(methylsulfonyl)-phenyl]ethanon |
| 03/03/2004 | EP1394147A1 Carboxylic acid derivative and medicine comprising salt or ester of the same |
| 03/03/2004 | EP1394142A1 Carboxylic acid intermediates of antifungal agents and processes for the preparation thereof |
| 03/03/2004 | EP1392680A2 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3 |
| 03/03/2004 | EP1392678A2 Process for the preparation of tetrasubstituted imidazole derivatives and novel crystalline structures thereof |
| 03/03/2004 | EP1392673A2 1,3-dihydroxybenzene derivatives and colorants containing said compounds |
| 03/03/2004 | EP1392661A1 Diarylurea derivatives useful as anti-inflammatory agents |
| 03/03/2004 | EP1392660A1 Substituted benzoylcyclohexenones and their use as herbicidal agents |
| 03/03/2004 | EP1392656A2 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors |
| 03/03/2004 | EP1392655A2 Potassium channel openers |
| 03/03/2004 | EP1392654A1 Integrin antagonists |
| 03/03/2004 | EP1392653A1 A short synthesis of pyridine-based pharmaceutical intermediates with sulfur-containing groups at the 2- and 3-positions |
| 03/03/2004 | EP1392652A1 Method for producing 1,3-disubstituted 2-nitroguanidines |
| 03/03/2004 | EP1392644A1 Cinnamide derivatives as kcnq potassium channel modulators |
| 03/03/2004 | EP1392643A2 Trisubstituted-n- (1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors |
| 03/03/2004 | EP1392642A2 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 03/03/2004 | EP1392641A1 Substituted cyclohexane-1,4-diamine derivatives |
| 03/03/2004 | EP1392639A1 Pyruvate derivatives |
| 03/03/2004 | EP1392637A2 Modulators of peroxisome proliferator activated receptors |
| 03/03/2004 | EP1392363A2 Compositions and uses of mglur5 antagonists |
| 03/03/2004 | EP1392315A1 Methods of treating alzheimer's disease |
| 03/03/2004 | EP1392302A1 5-substituted-2-arylpyridines as crf1 modulators |
| 03/03/2004 | EP1392300A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors |
| 03/03/2004 | EP1392219A2 Substituted n'-(arylcarbonyl)-benzhydrazides, n'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apotosis and the use thereof |
| 03/03/2004 | EP0929217B1 Sordarin derivatives |
| 03/03/2004 | EP0882714B1 Substituted vinylpyridine derivatives and drugs containing the same |
| 03/03/2004 | EP0758333B1 Intermediates in pharmaceutical camptothecin preparation |
| 03/03/2004 | CN1479727A Piperazinylpyrazine compounds as agonist or antagonist of 5-hydroxytryptamine 5HT-2 receptor |